Date Posted – 20 July 2021
Event Date – 23 July 2021
Presented by the Single-dose HPV Vaccine Evaluation Consortium in conjunction with VCS Foundation and the National Centre for Immunisation Research and Surveillance (Australia).
The Single-dose HPV Vaccine Evaluation Consortium recently released evidence on the potential for single-dose HPV vaccination to inform global policy discussions and program guidance, as well as to raise awareness and understanding of its implications. If demonstrated to be effective, single-dose HPV vaccination could facilitate new options for current national programs by simplifying delivery and lowering program costs, potentially accelerating introduction of HPV vaccines into national immunisation schedules.
This symposium will feature a presentation from, and a facilitated Q and A session with, members of the Consortium on existing and forthcoming evidence on the efficacy, immunogenicity, effectiveness, and cost effectiveness of single dose HPV vaccination from: